FDA Investigator Bryan Baker
Bryan Baker has conducted inspections on 79 sites in 1 countries as of 26 Aug 2009. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
79
Last Inspection Date:
26 Aug 2009
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Bryan Baker:
Aaron J Poloni,
Alexander M Kay,
Ashleigh P Barkans,
Ava M Bowman,
Brenda L Reihing,
Celia L Silverstein,
Dan G Eisenbrey,
Deborah Kleinfeld,
Dennis G Kawabata,
Dennis R Hudson,
Devon M Shoop,
Dianna D Wardlow Dotter,
Dolores E Price,
Donald W Jehn,
Edward D Harris,
Elizabeth S Howell,
Eric T Huebler,
Gina C Collins,
Gloria A Milster,
Gloria J Baca, MS,
Hanna L Potter,
Harmon M Blanch,
Jessica L Walters Moell,
John A Iwen,
John Cook,
John E Emmert,
Jonathan T Little,
Julian C Hanson,
Kaarin M Slotte,
Kathryn A Krentz,
Kelly D Moore,
Kip J Hanks,
Lauren E Swantko,
LCDR Ismael Olvera, IV,
Lee Terry Moore,
Lisa M Althar,
LTJG Bradley E Benasutti,
Lynn L Wong,
Marc A Jackson, Jr,
Marlene L Davis,
Mihaly S Ligmond,
Neil J Traaen,
Paul M Chefor,
Paula J Wilkerson,
Peter Kessler, PhD,
Peter T Regan,
Prabhu P Raju,
Rebecca T Davis,
Richard Heath Coats,
Richard L Bartlett,
Richard T Riggie,
Robert D Tollefsen,
Rocco C Black,
Scott A Nabe,
Shelley H Beausoleil,
Sherri N Rohlf, MD,
Stephen R Souza,
Sunitha K Rajaram, PhD,
Thomas C Mclean, CFS,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Victoria V Bot,
Young M Yoon
Bryan Baker's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2001 | FDA 483 | The American National Red Cross - Form 483, 2001-06-29 |
February, 2000 | FDA 483 | Oregon Health & Science University - Form 483, 2000-02-25 |
September, 2001 | FDA 483 | Bloodworks - Form 483, 2001-09-10 |
February, 2000 | EIR | Oregon Health & Science University - EIR, 2000-02-25 |
August, 2000 | FDA 483 | Lions Eye Bank of Oregon - Form 483, 2000-08-10 |
January, 2000 | EIR | The American National Red Cross - EIR, 2000-01-14 |
August, 2000 | EIR | Hawaii Lions Eye Bank and Makana Foundation - EIR, 2000-08-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more